Tango Therapeutics (NASDAQ:TNGX) is preparing to release its quarterly earnings on Thursday, 2026-03-05. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Tango Therapeutics to report an earnings per share (EPS) of $-0.32.
Investors in Tango Therapeutics are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Performance in Previous Earnings
The company’s EPS beat by $0.18 in the last quarter, leading to a 6.24% drop in the share price on the following day.
Here’s a look at Tango Therapeutics’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.04 | -0.35 | -0.35 | -0.34 |
| EPS Actual | 0.14 | -0.35 | -0.36 | -0.35 |
| Price Change % | -6.24 | -5.93 | 6.87 | -5.05 |
Stock Performance
Shares of Tango Therapeutics were trading at $11.5 as of March 03. Over the last 52-week period, shares are up 473.22%. Given that these …